Skip to main content
Top
Published in: Annals of Hematology 7/2006

01-07-2006 | Original Article

Distinct effects of different concentrations of sodium selenite on apoptosis, cell cycle, and gene expression profile in acute promyeloytic leukemia-derived NB4 cells

Authors: Ting-Ming Cao, Fang-Yuan Hua, Cai-Min Xu, Bing-She Han, Hua Dong, Lu Zuo, Xuan Wang, Yang Yang, Hua-Zhen Pan, Zhi-Nan Zhang

Published in: Annals of Hematology | Issue 7/2006

Login to get access

Abstract

Selenium at a low concentration has a chemopreventive role against cancer, while at a high concentration, it exerts a direct antitumor effect. However, the mechanisms remain elusive. In this article, we discovered that Na2SeO3 at 20 μmol/l concentration could significantly inhibit the proliferation of NB4 cells, affect the cell cycle distribution of cell population, and induce cellular changes characteristic of apoptotic cells, while this same compound at 2 μmol/l concentration had no such effects. The mechanisms underlying these overt differences caused by treatment of different concentrations of selenium were further investigated. cDNA microarray analysis showed that after treatment by 20 μmol/l Na2SeO3, 34 genes were changed in expression, while treatment by 2 μmol/l Na2SeO3 resulted in the changes of 29 genes. Nine genes were regulated in both groups, among which three showed opposite changes caused by 2 and 20 μmol/l Na2SeO3. The majority of regulated genes did not coincide between the two experiment groups. In conclusion, 2 and 20 μmol/l Na2SeO3 could have different effects on NB4 cells, and some genes might be involved in the underlying mechanisms. Our findings could provide basis for further uncovering the molecular mechanisms of the chemopreventive and antitumor effects of selenium and, in turn, for probing the rationality of treating leukemia with selenium.
Literature
1.
go back to reference Barrett JC, Kawasaki ES (2003) Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression. Drug Discov Today 8:134–141PubMedCrossRef Barrett JC, Kawasaki ES (2003) Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression. Drug Discov Today 8:134–141PubMedCrossRef
2.
go back to reference Bellosillo B, Dalmau M, Colomer D, Gil J (1997) Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood 89:3378PubMed Bellosillo B, Dalmau M, Colomer D, Gil J (1997) Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood 89:3378PubMed
3.
go back to reference Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias, French–American–British (FAB) co-operative group. Br J Haematol 33:451–458PubMedCrossRef Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias, French–American–British (FAB) co-operative group. Br J Haematol 33:451–458PubMedCrossRef
4.
go back to reference Camacho LH, Soignet SL, Chanel S, Ho R, Heller G, Scheinberg DA, Ellison R, Warrell RP Jr (2000) Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol 18:2620–2625PubMed Camacho LH, Soignet SL, Chanel S, Ho R, Heller G, Scheinberg DA, Ellison R, Warrell RP Jr (2000) Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol 18:2620–2625PubMed
5.
go back to reference Chen GQ, Shi X-G, Tang W, Xiong S-M, Zhu J, Cai X, Han Z-G, Ni J-H, Shi G-Y, Jia P-M, Liu M-M, He K-L, Niu C, Ma J, Zhang P, Zhang T-D, Paul P, Waxman Sl, Wang Z-Y, Chen S-J, Chen Z (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89:3345–3353PubMed Chen GQ, Shi X-G, Tang W, Xiong S-M, Zhu J, Cai X, Han Z-G, Ni J-H, Shi G-Y, Jia P-M, Liu M-M, He K-L, Niu C, Ma J, Zhang P, Zhang T-D, Paul P, Waxman Sl, Wang Z-Y, Chen S-J, Chen Z (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89:3345–3353PubMed
6.
go back to reference Diwadkar-Navsariwala V, Diamond AM (2004) The link between selenium and chemoprevention: a case for selenoproteins. J Nutr 134(11):2899–2902PubMed Diwadkar-Navsariwala V, Diamond AM (2004) The link between selenium and chemoprevention: a case for selenoproteins. J Nutr 134(11):2899–2902PubMed
7.
go back to reference Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC (2002). Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 11:630–639PubMed Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC (2002). Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 11:630–639PubMed
8.
go back to reference El-Bayoumy K (2001) The protective role of selenium on genetic damage and on cancer. Mutat Res 475:123–139PubMed El-Bayoumy K (2001) The protective role of selenium on genetic damage and on cancer. Mutat Res 475:123–139PubMed
9.
go back to reference El-Bayoumy K, Sinha R (2004) Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 13:181–197 El-Bayoumy K, Sinha R (2004) Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 13:181–197
10.
go back to reference Fenaux P, Chomienne C, Degos L (2001) All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 38:13–25PubMedCrossRef Fenaux P, Chomienne C, Degos L (2001) All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 38:13–25PubMedCrossRef
11.
go back to reference Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663–674PubMedCrossRef Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663–674PubMedCrossRef
12.
go back to reference Kastner P, Lawrence HJ, Waltzinger C, Ghyselinck NB, Chambon P, Chan S (2001) Positive and negative regulation of granulopoiesis by endogenous RARα. Blood 97:1314–1320PubMedCrossRef Kastner P, Lawrence HJ, Waltzinger C, Ghyselinck NB, Chambon P, Chan S (2001) Positive and negative regulation of granulopoiesis by endogenous RARα. Blood 97:1314–1320PubMedCrossRef
13.
go back to reference Kelly DL, Rizzino A (2000) DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells. Mol Reprod Dev 56:113–123PubMedCrossRef Kelly DL, Rizzino A (2000) DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells. Mol Reprod Dev 56:113–123PubMedCrossRef
14.
go back to reference Li J, Zuo L, Shen T, Zhang ZN (2002) Sodium selenite-induced oxidative stress and apoptosis in human acute promyelocytic leukemia NB4 cells. Yao Xue Xue Bao 37(9):677–681PubMed Li J, Zuo L, Shen T, Zhang ZN (2002) Sodium selenite-induced oxidative stress and apoptosis in human acute promyelocytic leukemia NB4 cells. Yao Xue Xue Bao 37(9):677–681PubMed
15.
go back to reference Li J, Zuo L, Shen T, Xu CM, Zhang ZN (2003) Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: involvement of oxidative stress and mitochondria. J Trace Elem Med Biol 17:19–26PubMedCrossRef Li J, Zuo L, Shen T, Xu CM, Zhang ZN (2003) Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: involvement of oxidative stress and mitochondria. J Trace Elem Med Biol 17:19–26PubMedCrossRef
16.
go back to reference Neve J (2002) Selenium as a nutraceutical: how to conciliate physiological and supra-nutritionaleffects for an essential trace element. Curr Opin Clin Nutr Metab Care 5:659–663PubMedCrossRef Neve J (2002) Selenium as a nutraceutical: how to conciliate physiological and supra-nutritionaleffects for an essential trace element. Curr Opin Clin Nutr Metab Care 5:659–663PubMedCrossRef
17.
go back to reference Raich PC, Lu J, Thompson HJ, Combs GF Jr (2001) Selenium in cancer prevention: clinical issues and implications. Cancer Invest 19:540–553PubMedCrossRef Raich PC, Lu J, Thompson HJ, Combs GF Jr (2001) Selenium in cancer prevention: clinical issues and implications. Cancer Invest 19:540–553PubMedCrossRef
19.
go back to reference Rowley JD, Golomb HM, Vardiman J, Fukuhara S, Dougherty C, Potter D (1977) Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia. Int J Cancer 20:869–872PubMedCrossRef Rowley JD, Golomb HM, Vardiman J, Fukuhara S, Dougherty C, Potter D (1977) Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia. Int J Cancer 20:869–872PubMedCrossRef
20.
go back to reference Sargent JM, Taylor CG (1989) Appraisa of the MTT assay as a rapid test of chemosenitivity in acute myeloid leukemia. Br J Cancer 60:206–210PubMed Sargent JM, Taylor CG (1989) Appraisa of the MTT assay as a rapid test of chemosenitivity in acute myeloid leukemia. Br J Cancer 60:206–210PubMed
21.
go back to reference Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH Jr (1998) Arsenic trioxide as aninducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 90:124–133PubMedCrossRef Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH Jr (1998) Arsenic trioxide as aninducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 90:124–133PubMedCrossRef
22.
go back to reference Slack JL, Rusiniak ME (2000) Current issues in the management of acute promyelocytic leukemia. Ann Hematol 79:227–238PubMedCrossRef Slack JL, Rusiniak ME (2000) Current issues in the management of acute promyelocytic leukemia. Ann Hematol 79:227–238PubMedCrossRef
23.
go back to reference Stratton MS, Reid ME, Schwartzberg G, Minter FE, Monroe BK, Alberts DS, Marshall JR, Ahmann FR (2003) Selenium and prevention of prostate cancer in high-risk men: the negative biopsy study. Anticancer Drugs 14:589–594PubMedCrossRef Stratton MS, Reid ME, Schwartzberg G, Minter FE, Monroe BK, Alberts DS, Marshall JR, Ahmann FR (2003) Selenium and prevention of prostate cancer in high-risk men: the negative biopsy study. Anticancer Drugs 14:589–594PubMedCrossRef
24.
go back to reference Zuo L, Li J, Shen T, Zhang ZN (2002) The comparison between the mechanisms of sodium selenite induced apoptosis and arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line NB4 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 10:195–200PubMed Zuo L, Li J, Shen T, Zhang ZN (2002) The comparison between the mechanisms of sodium selenite induced apoptosis and arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line NB4 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 10:195–200PubMed
25.
go back to reference Zuo L, Li J, Yang Y, Wang X, Shen T, Xu CM, Zhang ZN (2004) Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Ann Hematol 83(12):751–758PubMedCrossRef Zuo L, Li J, Yang Y, Wang X, Shen T, Xu CM, Zhang ZN (2004) Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Ann Hematol 83(12):751–758PubMedCrossRef
Metadata
Title
Distinct effects of different concentrations of sodium selenite on apoptosis, cell cycle, and gene expression profile in acute promyeloytic leukemia-derived NB4 cells
Authors
Ting-Ming Cao
Fang-Yuan Hua
Cai-Min Xu
Bing-She Han
Hua Dong
Lu Zuo
Xuan Wang
Yang Yang
Hua-Zhen Pan
Zhi-Nan Zhang
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 7/2006
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-005-0046-4

Other articles of this Issue 7/2006

Annals of Hematology 7/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.